Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Peptide & Protein Research   Volumes    Volume 7 
Antimicrobial peptides produced by Staphylococcus sp. strains isolated in Brazil
Maria do Carmo de Freire Bastos, Hilana Ceotto, Janaína dos Santos Nascimento
Pages: 23 - 28
Number of pages: 6
Current Topics in Peptide & Protein Research
Volume 7 

Copyright © 2005 Research Trends. All rights reserved


Bacteriocins are proteinaceous compounds with bactericidal activity against other bacteria. Our laboratory has been investigating bacteriocin production by Staphylococcus sp. strains from different sources. Two bacteriocins produced by S. aureus (aureocins) were characterized at the molecular and biochemical levels. Aureocin A53 is an atypical class II bacteriocin produced by S. aureus A53 isolated from commercial milk. This antimicrobial peptide is encoded by a 10.4–kb plasmid (pRJ9) and is able to inhibit several Gram-positive bacteria, including Listeria monocytogenes, streptococcal strains involved in bovine mastitis and staphylococcal strains associated to human infections and bovine mastitis. Aureocin A53 is a highly cationic 51-residue, non-processed peptide. Further unique features of aureocin A53 include remarkable protease stability and a defined, rigid structure in aqueous solution. Strain S. aureus A70, also isolated from commercial milk, produces a class II bacteriocin called aureocin A70 that inhibits a variety of Gram-positive bacteria, including also L. monocytogenes. Aureocin A70 is encoded by a mobilisable 8.0-kb plasmid, pRJ6, which has been found in other strains of S. aureus and coagulase-negative staphylococci. Aureocin A70 was the first bacteriocin described which is composed of four related small (30-31 amino acid residues) cationic peptides. Aureocin A70 is also expressed and excreted without post-translational modifications. Recently, a new bacteriocin produced by an S. simulans strain, simulancin 3299, has been identified by our group. This bacteriocin presents a high antagonistic activity against Streptococcus agalactiae involved in bovine mastitis. According to our knowledge, this was the first report on bacteriocin production by S. simulans.

Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms